Tech Mahindra’s healthcare and life sciences vertical has been recognized as a Leader and Rising Star in the ISG Provider Lens Study for Life Sciences Digital Services 2024. The report has recognized Tech Mahindra as a Leader for its transformative approach to clinical trials, which integrates next-gen solutions to optimize study management and enhance patient engagement. Additionally, Tech Mahindra has been recognized as a Rising Star for its innovative platforms that streamline healthcare delivery and personalize patient experiences on a global scale.
Tech Mahindra's platforms, including HealthNxt, Advanced Clinical Platform, GLAMs and Discovery Research are at the forefront of enabling digital transformation across the life sciences value chain. These platforms leverage GenAI capabilities to fast-track drug discovery, improve patient experience, and streamline the supply chain. As part of Tech Mahindra's strategic focus on the healthcare and life sciences sector, the company is making significant investments in GenAI to enhance its capabilities in data-driven insights, workflow automation, and personalized patient care.
Tech Mahindra represents the connected world, offering innovative and customer-centric information technology experiences, enabling Enterprises, Associates and the Society to Rise.
Company Name | CMP |
---|---|
TCS | 4168.05 |
Infosys | 1922.05 |
HCL Tech. | 1911.20 |
Wipro | 305.15 |
Tech Mahindra | 1685.20 |
View more.. |